Regulus Therapeutics Inc (NASDAQ:RGLS)

Delayed Data
As of Jan 24
 -0.0241 / -10.76%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Regulus Therapeutics Inc have a median target of 1.25, with a high estimate of 2.00 and a low estimate of 0.42. The median estimate represents a +525.31% increase from the last price of 0.20.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Regulus Therapeutics Inc. This rating has held steady since December, when it was upgraded from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 25.00%
Growthannually 25.56%


Growthquarterly --
Growthannually -99.96%
Key to the earnings and sales forecast charts.